Cellebrite Shares Hit $12.50 Price Target
Ticker: CLBT · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1854587
| Field | Detail |
|---|---|
| Company | Cellebrite Di Ltd. (CLBT) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $12.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, stock-performance, 6-K
TL;DR
Cellebrite's stock hit $12.50 for 20 days straight, triggering something in their docs.
AI Summary
Cellebrite DI Ltd. announced on August 14, 2024, that its ordinary shares achieved a dollar volume-weighted average price of at least $12.50 for the 20th trading day within a 30-day period. This "Triggering Event" was disclosed in a Form 6-K filing.
Why It Matters
This event may trigger certain provisions in the company's agreements, potentially impacting its financial structure or obligations.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a stock price milestone and does not indicate new negative events.
Key Numbers
- $12.50 — Average Share Price (Minimum price achieved for 20 trading days)
- 20 — Trading Days (Number of days the average price was met)
- 30 — Trading Day Period (The window within which the 20 days were met)
Key Players & Entities
- Cellebrite DI Ltd. (company) — Registrant
- August 14, 2024 (date) — Date of Triggering Event
- $12.50 (dollar_amount) — Minimum average share price
FAQ
What is the specific nature of the "Triggering Event" mentioned in the filing?
The "Triggering Event" is defined as the dollar volume-weighted average price of Cellebrite's ordinary shares being greater than or equal to $12.50 per share for a twentieth trading day within a thirty trading-day period.
When did this "Triggering Event" occur?
The "Triggering Event" occurred on August 14, 2024.
What type of filing is this document?
This document is a Form 6-K, which is a Report of Foreign Private Issuer.
What is the company's principal executive office address?
The company's principal executive office is located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
Does Cellebrite file annual reports under Form 20-F or Form 40-F?
Cellebrite indicates it files annual reports under Form 20-F.
Filing Stats: 410 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2024-08-15 07:00:25
Key Financial Figures
- $12.50 — s ”) was greater than or equal to $12.50 per share for a twentieth trading day w
Filing Documents
- ea021144201-6k_cellebrite.htm (6-K) — 11KB
- 0001213900-24-069339.txt ( ) — 12KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellebrite DI Ltd. Date: August 15, 2024 By: /s/ Dana Gerner Dana Gerner Chief Financial Officer